Related Experiment Video

Updated: Aug 23, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Endothelin-1 and nitric oxide levels in patients with mitral annulus calcification

Ahmet Camsari1, Hasan Pekdemir, Dilek Ciçek

  • 1Department of Cardiology, Faculty of Medicine, Mersin University, Mersin, Turkey.

Japanese Heart Journal
|July 9, 2004
PubMed

Insights

Patients with mitral annulus calcification (MAC) show elevated endothelin-1 (ET-1) and reduced nitric oxide (NOx) levels. These changes are more pronounced in severe MAC cases, suggesting a role in disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Mitral annulus calcification (MAC) is a chronic degenerative condition.
  • The roles of endothelin-1 (ET-1) and nitric oxide (NOx) in MAC pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate plasma levels of ET-1 and NOx in patients with MAC.
  • To compare these levels with those in healthy subjects.
  • To assess the correlation between ET-1/NOx levels and MAC severity.

Main Methods:

  • Cross-sectional study comparing 39 MAC patients with 20 healthy controls.
  • MAC patients were stratified into severe (Group A) and mild (Group B) subgroups.
  • Plasma ET-1 and NOx levels were measured and compared across groups.

Main Results:

  • MAC patients exhibited significantly higher ET-1 and lower NOx levels than controls.
  • Severe MAC (Group A) showed higher ET-1 and lower NOx compared to mild MAC (Group B) and controls.
  • ET-1 levels correlated with diabetes, coronary artery disease, and dyslipidemia.

Conclusions:

  • Patients with MAC have an imbalance of ET-1 and NOx, with increased ET-1 and decreased NOx.
  • This imbalance is particularly evident in severe MAC, indicating its potential contribution to disease severity.

More Related Videos

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification08:55

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

Published on: November 20, 2017

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...